TI
IONS icon

Telemetry Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Telemetry Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,780
Closed -$299K – 148
2018
Q1 		$299K Buy
+6,780
New +$344K 0.11% 94
2017
Q4 		– Sell
-6,180
Closed -$313K – 148
2017
Q3 		$313K Buy
+6,180
New +$324K 0.11% 94

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Telemetry Investments's IONS Position: Q2 2018 in Review

Telemetry Investments sold out of Ionis Pharmaceuticals (IONS) in Q2 2018, closing a stake of 6,780 shares — an estimated $299K sold.

Telemetry Investments first reported a position in IONS in Q3 2017 and held it in 2 quarters. The position peaked at $313K in Q3 2017. 308 funds tracked by Wall St. Rank hold IONS as of Q2 2018.

  • Telemetry Investments reported no remaining Ionis Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Telemetry Investments sold 6,780 Ionis Pharmaceuticals shares in Q2 2018, an estimated $299K.
  • Telemetry Investments first reported a position in Ionis Pharmaceuticals in Q3 2017 and held it in 2 quarters.
  • Telemetry Investments's Ionis Pharmaceuticals position peaked at $313K in Q3 2017.
  • 308 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2018.

Based on Telemetry Investments's 13F filing for Q2 2018, filed 14 Aug 2018.